MedPath

Effects of Combined Spinal Direct Current Stimulation on Upper Limb Recovery in Acquired Brain Injury

Not Applicable
Terminated
Conditions
Acquired Brain Injury
Interventions
Device: tsDCS-Anodal Stimulation
Device: tsDCS-Cathodal Stimulation
Device: tsDCS-Sham Stimulation
Device: Robotic-assisted training of arm and hand functions
Registration Number
NCT03100370
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

This study will compare different polarities of transcutaneous spinal direct current stimulation combined with robotic-assisted arm training (RAT) in adults with acquired brain injury (ABI). Participants will receive 20 minutes of 2.5 milliamps (mA) anodal, cathodal, and sham transpinal direct current stimulation (tsDCS) over cervical spine combined with high intensity robotic-assisted arm training, five days a week, for 2 consecutive weeks.

Detailed Description

Acquired brain injury (ABI) is the leading cause of neurological disability in the United States and accounts for the poor physical health and the social dysfunction evident in survivors. Hemiparesis due to acquired brain injury is the primary cause of disability and arm paresis is perceived as the primary cause of disability by individuals who have suffered ABI because of the limitations it creates in performing activities of daily living (ADL). Rehabilitation of the impaired limb is essential for improving motor function after ABI, yet only 31% of ABI survivors receive outpatient rehabilitation. Therefore, effective therapy for upper-limb paresis must be addressed. Approximately 80% of all ABI survivors suffer from upper limb paresis and only 18% of these individuals gain full motor recovery with conventional treatments in the year following ABI.

The study will use cross-over, randomized, sham controlled, double-blinded design. Participants with subacute or chronic ABI will each be assigned to receive active anodal spinal stimulation, active cathodal spinal stimulation, and sham spinal stimulation for the same duration, and the order that each participant will receive anodal, cathodal, and sham stimulation will be randomized. In all the experiments participants will receive robotic assisted training for duration of 1.5 hours. The first 20 minutes of training will be coupled with spinal stimulation. Treatment will be administered at an intensity of 5 sessions per week for 2 weeks.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
9
Inclusion Criteria
  1. Providing written informed consent prior to any study related procedures;

  2. Age above 18;

  3. Diagnosis of acquired brain injury at least for 6 month

  4. No neuropsychiatric comorbidities

  5. Not being involved in any specific exercise program (e.g., neuromuscular electrical stimulation (NMES), functional electrical stimulation (FES)) within the previous 3 months;

  6. No planned alteration in upper-extremity therapy or medication for muscle tone during the course of the study;

  7. Eligibility for standard upper-extremity rehabilitation at the time of enrollment (i.e., absence medical comorbidities that would prevent standard rehabilitation);

  8. No condition (e.g., severe arthritis, extreme shoulder pain) that would interfere with valid administration of the measures or with interpreting motor testing;

  9. No contraindications to tsDCS:

    • metal in the head between stimulation area
    • metal in the spine between stimulation area
    • implanted brain medical devices
  10. No pregnancy;

  11. No contraindications for Transcranial Magnetic Stimulation (TMS) and magnetic resonance imaging (MRI) based on TMS and MRI screening forms

Exclusion Criteria
  1. Uncontrolled epilepsy;
  2. Any joint contracture or severe spasticity in the affected upper extremity, as measured by a Modified Ashworth Score > than 3 out of 4;
  3. History of substance abuse;
  4. Subject who cannot provide self-transportation to the study location

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
tsDCS-Anodal & robotic arm training (RAT), then tsDCS-Cathodal & RAT, then tsDCS-Sham & RATtsDCS-Cathodal Stimulationanodal tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Anodal & robotic arm training (RAT), then tsDCS-Cathodal & RAT, then tsDCS-Sham & RATRobotic-assisted training of arm and hand functionsanodal tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Anodal & robotic arm training (RAT), then tsDCS-Cathodal & RAT, then tsDCS-Sham & RATtsDCS-Sham Stimulationanodal tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Sham & robotic arm training (RAT), then tsDCS-Cathodal & RAT, then tsDCS-Anodal & RATtsDCS-Anodal Stimulation-
tsDCS-Cathodal & robotic arm training (RAT), then tsDCS-Anodal & RAT, then tsDCS-Sham & RATtsDCS-Sham Stimulationsham tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Cathodal & robotic arm training (RAT), then tsDCS-Anodal & RAT, then tsDCS-Sham & RATRobotic-assisted training of arm and hand functionssham tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Cathodal & robotic arm training (RAT), then tsDCS-Sham & RAT, then tsDCS-Anodal & RATtsDCS-Sham Stimulation-
tsDCS-Cathodal & robotic arm training (RAT), then tsDCS-Sham & RAT, then tsDCS-Anodal & RATtsDCS-Anodal Stimulation-
tsDCS-Cathodal & robotic arm training (RAT), then tsDCS-Anodal & RAT, then tsDCS-Sham & RATtsDCS-Cathodal Stimulationsham tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Cathodal & robotic arm training (RAT), then tsDCS-Sham & RAT, then tsDCS-Anodal & RATtsDCS-Cathodal Stimulation-
tsDCS-Sham & robotic arm training (RAT), then tsDCS-Anodal & RAT, then tsDCS- Cathodal & RATtsDCS-Cathodal Stimulation-
tsDCS-Sham & robotic arm training (RAT), then tsDCS-Cathodal & RAT, then tsDCS-Anodal & RATtsDCS-Cathodal Stimulation-
tsDCS-Anodal & robotic arm training (RAT), then tsDCS-Cathodal & RAT, then tsDCS-Sham & RATtsDCS-Anodal Stimulationanodal tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Anodal & robotic arm training (RAT), then tsDCS-Sham & RAT, then tsDCS-Cathodal & RATtsDCS-Anodal Stimulationcathodal tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Cathodal & robotic arm training (RAT), then tsDCS-Sham & RAT, then tsDCS-Anodal & RATRobotic-assisted training of arm and hand functions-
tsDCS-Sham & robotic arm training (RAT), then tsDCS-Cathodal & RAT, then tsDCS-Anodal & RATRobotic-assisted training of arm and hand functions-
tsDCS-Anodal & robotic arm training (RAT), then tsDCS-Sham & RAT, then tsDCS-Cathodal & RATtsDCS-Cathodal Stimulationcathodal tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Cathodal & robotic arm training (RAT), then tsDCS-Anodal & RAT, then tsDCS-Sham & RATtsDCS-Anodal Stimulationsham tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Sham & robotic arm training (RAT), then tsDCS-Cathodal & RAT, then tsDCS-Anodal & RATtsDCS-Sham Stimulation-
tsDCS-Anodal & robotic arm training (RAT), then tsDCS-Sham & RAT, then tsDCS-Cathodal & RATtsDCS-Sham Stimulationcathodal tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Anodal & robotic arm training (RAT), then tsDCS-Sham & RAT, then tsDCS-Cathodal & RATRobotic-assisted training of arm and hand functionscathodal tsDCS over cervical spine, 2.5mA for 20 minutes
tsDCS-Sham & robotic arm training (RAT), then tsDCS-Anodal & RAT, then tsDCS- Cathodal & RATtsDCS-Anodal Stimulation-
tsDCS-Sham & robotic arm training (RAT), then tsDCS-Anodal & RAT, then tsDCS- Cathodal & RATtsDCS-Sham Stimulation-
tsDCS-Sham & robotic arm training (RAT), then tsDCS-Anodal & RAT, then tsDCS- Cathodal & RATRobotic-assisted training of arm and hand functions-
Primary Outcome Measures
NameTimeMethod
Fugl-Meyer Arm (FMA) Motor Score1 month

FMA is a stroke-specific, performance based impairment index. It quantitatively measures impairment based on Twitchell and Brunnstrom's concept of sequential stages of motor return in hemiplegic stroke patients. It uses an ordinal scale for scoring of 33 items for the upper limb component of the F-M scale (0:can not perform; 1:can perform partially; 2:can perform fully). Total range is 0-66, 0 being poor and 66 normal.

Secondary Outcome Measures
NameTimeMethod
Spinal ReflexesChange from baseline at 2 weeks and at 1 month
Neurophysiologic Testing for Spinal Conductivity (SSEP)Change from baseline at 2 weeks and at 1 month
Jebsen Taylor Hand Function Test (JTHFT)1 month

The JTHFT is a motor performance test and assesses the time needed to perform 7 everyday activities (for example, flipping cards and feeding). Score is reported as items completed per second.

Spasticity as Assessed by the Modified Ashworth Scale (MAS)1 month

This test measures spasticity in patients with lesions of the Central Nervous System by testing resistance to passive movement about a joint with varying degrees of velocity. Scores range from 0-4, with 0 indicating normal muscle tone and 4 indicating very high spasticity. The investigators will measure spasticity in the trained upper limb.

Motor Activity Log (MAL)1 month

The MAL ranges from 0 to 5, with a higher score indicating greater ability to use the affected arm.

Pinch Strength1 month

A pinch gauge will be used to measure maximum pinch force.

Number of Participants With Adverse Effects Related to tsDCS1 month

Safety will be measured by questioning and observing participants at each treatment session. Adverse effects, such as skin redness etc. will be recorded.

Change in Strength of Selective Muscle GroupsChange from baseline at 2 weeks and at 1 month
Action Research Arm Test (ARAT)1 month

The ARAT is used to assess subject's ability to manipulate-lift-release objects horizontally and vertically, which differs in size, weight and shape. The test consists of 19 items divided into 4 sub-tests (grasp, grip, pinch, gross arm movement) and each item is rated on a 4-point scale. The possible total score ranges between 0-57. Higher scores indicate better performance.

Quantitative Movement MeasurementChange from baseline at 2 weeks and at 1 month

Robotic movement data will be used to quantitatively measure changes in movement smoothness

Grip Strength1 month

A grip dynamometer will be used to measure maximum gross grasp force.

Trial Locations

Locations (1)

The Institute for Rehabilitation and Research (TIRR) at Memorial Hermann

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath